Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease
Endothelial Dysfunction
DOI:
10.1161/atvbaha.114.304108
Publication Date:
2014-10-24T03:34:32Z
AUTHORS (28)
ABSTRACT
Interleukin (IL)-17A is regarded as an important cytokine to drive psoriasis, inflammatory skin disease marked by increased cardiovascular mortality. We aimed test the hypothesis that overproduction of IL-17A in leading dermal inflammation may systemically cause vascular dysfunction psoriasis-like disease.Conditional overexpression keratinocytes caused severe mice (K14-IL-17A(ind/+) mice), associated with reactive oxygen species formation and circulating CD11b(+) leukocytes blood, endothelial dysfunction, systolic blood pressure, left ventricular hypertrophy, reduced survival compared controls. In K14-IL-17A(ind/+) mice, immunohistochemistry flow cytometry revealed production nitric oxide/superoxide reaction product peroxynitrite infiltration vasculature myeloperoxidase(+)CD11b(+)GR1(+)F4/80(-) cells accompanied expression inducible oxide synthase nicotinamide dinucleotide phosphate (NADPH) oxidase, nox2. Neutrophil depletion anti-GR-1 antibody injections oxidative stress vessels. Neutralization tumor necrosis factor-α IL-6 (both downstream IL-17A) lesions, attenuated heart partially improved mice.Dermal induces systemic stress, arterial hypertension, increases mortality mainly driven cells. Depletion GR-1(+) immune or neutralization cytokines biologicals attenuates phenotype mice.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (52)
CITATIONS (205)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....